Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma
Joint Authors
Pierorazio, Phillip M.
Allaf, Mohamad E.
Campbell, Scott P.
Song, Daniel Y.
Gorin, Michael A.
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-11-11
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Thermal ablation is currently the most studied treatment option for medically inoperable patients with clinically localized renal cell carcinoma (RCC).
Recent evidence suggests that stereotactic ablative radiotherapy (SABR) may offer an effective noninvasive alternative for these patients.
In this review, we explore the current literature on SABR for the primary treatment of RCC and make recommendations for future studies so that an accurate comparison between SABR and other ablative therapies may be conducted.
American Psychological Association (APA)
Campbell, Scott P. & Song, Daniel Y.& Pierorazio, Phillip M.& Allaf, Mohamad E.& Gorin, Michael A.. 2015. Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma. Journal of Oncology،Vol. 2015, no. 2015, pp.1-6.
https://search.emarefa.net/detail/BIM-1069573
Modern Language Association (MLA)
Campbell, Scott P.…[et al.]. Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma. Journal of Oncology No. 2015 (2015), pp.1-6.
https://search.emarefa.net/detail/BIM-1069573
American Medical Association (AMA)
Campbell, Scott P. & Song, Daniel Y.& Pierorazio, Phillip M.& Allaf, Mohamad E.& Gorin, Michael A.. Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma. Journal of Oncology. 2015. Vol. 2015, no. 2015, pp.1-6.
https://search.emarefa.net/detail/BIM-1069573
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1069573
